Product Overview
What It Is:
GLP-1 S refers to a synthetic GLP-1 receptor agonist, commonly modeled after semaglutide, a glucagon-like peptide-1 analog. This peptide mimics the effects of naturally occurring GLP-1, a hormone that regulates appetite, insulin secretion, and blood glucose levels.
Chemical Structure:
Semaglutide is a modified GLP-1 analog with 94% homology to human GLP-1. It includes structural substitutions that extend its half-life and increase binding affinity for the GLP-1 receptor.
Effects:
GLP-1 S enhances insulin secretion in response to meals while suppressing glucagon release, leading to improved glycemic control. It delays gastric emptying and acts on appetite centers in the brain, contributing to reduced food intake and significant weight loss. Clinical trials have demonstrated its effectiveness in reducing HbA1c levels, supporting cardiovascular health, and promoting sustainable fat loss in individuals with obesity or type 2 diabetes.
